HenryMKuererMDPhD, FACS
General Surgery • Houston, TXBreast, Surgical Oncology (Other than Breast)
Professor and Medical Director, MD Anderson Cancer Center
Dr. Kuerer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Breast Surgical Oncology, 1997 - 1998
Icahn School of Medicine at Mount SinaiResidency, Surgery, 1992 - 1997
State University of New York Downstate Medical Center College of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1998 - Present
FL State Medical License 2021 - Present
TX State Medical License 1997 - 2024- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Regents Outstanding Teacher Award University of Texas Board of Regents, 2014
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast Start of enrollment: 2005 Mar 01
- Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) Start of enrollment: 2008 May 01
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Join now to see all
Publications & Presentations
PubMed
- ASO Visual Abstract: Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.Ashley A Woodfin, Clinton Yam, Mediget Teshome, Henry M Kuerer, Kelly K Hunt
Annals of Surgical Oncology. 2024-04-01 - Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement.Susie X Sun, Matthew J Piotrowski, Taiwo Adesoye, Melissa P Mitchell, Haven R Garber
Journal of the American College of Surgeons. 2024-01-01 - ASO Visual Abstract: Extremely Low Incidence of Local-Regional Recurrences Observed among T1-2N1 (one or two Positive SLNs) Breast Cancer Patients Receiving Upfront Ma...Shruti Zaveri, Shlermine Everidge, Elizabeth FitzSullivan, Rosa Hwang, Benjamin D Smith
Annals of Surgical Oncology. 2023-11-01
Journal Articles
- OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer PatientsI Bedrosian, K K Hunt, A Lucci, D M Black, H M Kuerer, M Teshome, A S Caudle, S M DeSnyder, R F Hwang, Annals of Surgical Oncology
- Association of Low Nodal Positivity Rate Among Patients with ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Che...Henry M Kuerer, Judy C Boughey, Alison U Barron, E Shelley Hwang, JAMA
- American Society of Breast Surgeons’ Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery with W...Anthony Lucci, Kelly K Hunt, Benjamin D Smith, Sarah M DeSnyder, Henry M Kuerer, Annals of Surgical Oncology
- Join now to see all
Press Mentions
DCIS Breast Cancer Survivor Sees Hope All Around HerDecember 11th, 2019
Breast Biopsies After Neoadjuvant Chemotherapy Accurately Predict Presence of Residual Breast CancerDecember 10th, 2019
Can Some HER2-Positive Breast Cancer Patients Avoid Surgery?May 14th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
